1. Home
  2. KSS vs FTRE Comparison

KSS vs FTRE Comparison

Compare KSS & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kohl's Corporation

KSS

Kohl's Corporation

SELL

Current Price

$22.04

Market Cap

1.9B

ML Signal

SELL

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

SELL

Current Price

$21.79

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
KSS
FTRE
Founded
1962
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
KSS
FTRE
Price
$22.04
$21.79
Analyst Decision
Hold
Buy
Analyst Count
14
13
Target Price
$18.88
★ $21.04
AVG Volume (30 Days)
★ 3.5M
1.5M
Earning Date
11-24-2026
10-29-2026
Dividend Yield
★ 2.36%
N/A
EPS Growth
★ 142.86
N/A
EPS
★ 1.18
N/A
Revenue
N/A
★ $2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.04
$3.19
P/E Ratio
$17.92
★ N/A
Revenue Growth
N/A
★ 1.00
52 Week Low
$11.38
$8.55
52 Week High
$25.22
$23.51

Technical Indicators

Market Signals
Indicator
KSS
FTRE
Relative Strength Index (RSI) 75.31 66.73
Support Level $16.19 $16.92
Resistance Level N/A $23.51
Average True Range (ATR) 0.89 1.05
MACD 0.33 0.09
Stochastic Oscillator 99.32 62.89

Price Performance

Historical Comparison
KSS
FTRE

About KSS Kohl's Corporation

Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: